Damora Therapeutics, Inc. (DMRA)
30.48
-0.14
(-0.46%)
USD |
NASDAQ |
Aug 26, 16:00
30.48
0.00 (0.00%)
After-Hours: 18:54
Damora Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.0026 |
| December 31, 2025 | 0.0059 |
| September 30, 2025 | 0.212 |
| June 30, 2025 | 0.1473 |
| March 31, 2025 | 0.116 |
| December 31, 2024 | 0.099 |
| September 30, 2024 | 0.0015 |
| June 30, 2024 | 0.0033 |
| March 31, 2024 | 0.0055 |
| December 31, 2023 | 0.0077 |
| September 30, 2023 | 0.0124 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.0143 |
| March 31, 2023 | 0.0136 |
| December 31, 2022 | 0.013 |
| September 30, 2022 | 0.0118 |
| June 30, 2022 | 0.0067 |
| March 31, 2022 | 0.0072 |
| December 31, 2021 | 0.0072 |
| September 30, 2021 | 0.0072 |
| June 30, 2021 | 0.0077 |
| March 31, 2021 | 0.0063 |
| December 31, 2020 | 0.0055 |
| September 30, 2020 | 0.0101 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 543.64M |
| Total Liabilities (Quarterly) | 27.58M |
| Shareholders Equity (Quarterly) | 516.06M |
| Current Ratio | 19.73 |
| Net Debt Paydown Yield | 0.02% |